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Cystic fibrosis (CF) patients are highly susceptible to chronic lung
infections by the environmental bacterium Pseudomonas aerugi-
nosa. The overproduction and accumulation of dehydrated viscous
respiratory mucus and excessive inflammation represents a defin-
ing feature of CF and constitutes the major environment encoun-
tered by P. aeruginosa during chronic infections. We applied
whole-genome microarray technology to investigate the ability of
P. aeruginosa to respond to signals found in muco-purulent airway
liquids collected from chronically infected CF patients. Particularly
notable was the activation of the Rhl-dependent quorum-sensing
(QS) network and repression of fliC, which encodes flagellin.
Activation of the Rhl branch of the QS network supports the
observation that QS molecules are produced in the chronically
infected CF lung. The shut-off of flagellin synthesis in response to
CF airway liquids was rapid and independent of QS and the known
regulatory networks controlling the hierarchical expression of
flagellar genes. As flagellin is highly immunogenic and subject to
detection by host pattern recognition receptors, its repression may
represent an adaptive response that allows P. aeruginosa to avoid
detection by host defense mechanisms and phagocytosis during
the chronic phase of CF lung infections.
Anumber of environmental microorganisms possess the abil-ity to cause serious human infections. These life-threatening
situations result from a combination of factors, including host
predisposition and the ability of these opportunistic pathogens to
regulate expression of specific virulence factors in response to
the changing host environment. For example, cystic fibrosis (CF)
patients are highly susceptible to chronic lung infections by the
environmental bacterium Pseudomonas aeruginosa (1). The pre-
disposition of these individuals is a consequence of the pleio-
tropic effects of mutations in the host gene encoding the CF
transmembrane conductance regulator (CFTR), but the patho-
genesis of CF lung infections is poorly understood.
Several hypotheses have been proposed to explain this hyper-
susceptibility, including deficient antimicrobial peptide activity,
reduced production of nitric oxide, increased adherence of
bacteria to epithelial cells, and decreased epithelial cell ingestion
(2). However, consistent in vivo evidence for these hypotheses
has not yet emerged. It is likely, however, that defective mucus
clearance contributes to the infection process. Mucus clearance
is a key mechanism for defending the respiratory tract from
bacterial challenge (3). Protection may in part be mediated by
the ability of airway surface liquid components to specifically
bind to pathogenic bacterial species and facilitate their removal.
This clearance mechanism becomes defective because of specific
genetic or acquired disorders. Recent studies indicate that in CF
airways altered ion transport and accelerated airway surface
liquid absorption results in decreased volume of the periciliary
liquid layer, leading to mucus stagnation and the accumulation
of adherent mucus plugs (4, 5). A number of studies have shown
that during chronic CF lung infections P. aeruginosa resides
within the viscous mucus layer and appears to form macrocolo-
nies or biofilms embedded in mucus obstructions (6, 7). Despite
these findings, it remains unclear why P. aeruginosa infections
predominate in the CF lung given the myriad of infectious organ-
isms that are likely encountered. We propose that adaptive micro-
bial behavior may play a key role in enhancing the preferential
survival and persistence of P. aeruginosa in this environment.
Although most P. aeruginosa strains in the environment rarely
encounter a suitable human host, they possess a set of highly
conserved genes encoding virulence determinants whose prod-
ucts have specific host targets (8). The pathogenesis of P.
aeruginosa lung infections in CF likely requires the coordinately
regulated expression of distinct sets of virulence determinants at
different disease stages. As such, the genes necessary for initi-
ation of infection from an environmental reservoir likely differ
from those required for persistence and chronic infection. To
recognize the adaptive responses that occur during the chronic
phase of CF infections, we identified all of the genes differen-
tially expressed by P. aeruginosa during growth in muco-purulent
respiratory liquid (defined here as muco-purulent material,
MPM) derived from chronically infected adult CF patients.
We show that exposure of P. aeruginosa to MPM from CF
patients results in the activation of the Rhl-dependent quorum-
sensing (QS) network and repression of a number of genes
encoded proteins involved in or predicted to be involved in
flagellar-mediated chemotactic motility including fliC, which
encodes flagellin. Activation of the Rhl branch of the QS
network indicates that bacterial cell-to-cell signaling molecules
are present in CF respiratory liquid at biologically active con-
centrations and further supports the observation that QS mol-
ecules are produced during chronic CF lung disease (9). By
comparing the transcriptional response of wild-type P. aerugi-
nosa and QS signaling mutants, we identified a number of
QS-dependent genes that appear to be specific to the CF airway
environment.
Furthermore we discovered that in chronically infected CF
airway liquid P. aeruginosa f lagellin expression is repressed. The
shut-off of f lagellin is rapid, resulting in an 80% reduction of fliC
mRNA within 2 h of MPM exposure. After prolonged exposure,
fliC mRNA, flagellin, and flagellar filaments could not be
detected. The repression of fliC expression was independent of
QS and the known regulatory networks controlling the hierar-
chical expression of flagellar genes.
We propose that the cessation of fliC expression, as well as
other transcriptional events including activation of the QS
network, represent adaptive responses that contribute to the
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selective persistence of P. aeruginosa during the chronic phase of
CF lung infections. The findings presented here provide insight
into the transcriptional adaptations that occur during the patho-
genesis of P. aeruginosa lung infections in CF.
Materials and Methods
Bacterial Strains, Media, and Transcriptional Profiling. For transcrip-
tional profiling, wild-type P. aeruginosa strain PAK and an
isogenic QS mutant lacking the acyl-homoserine lactone (HSL)
responsive transcriptional regulators RhlR and LasR were used.
The QS mutant was constructed by sequentially deleting the
coding sequences of rhlR and lasR by a previously described
technique (10). Bacteria were grown at 37°C in 12.5 ml of M63
medium [15 mM (NH4)2SO422 mM KH2PO440 mM
K2HPO440 mM glucose1 mM MgSO425 M FeCl2] or in
M63 supplemented with 10% (volvol) MPM collected from CF
patients. MPM was obtained at the University of Florida Medical
Center after chest physiotherapy to clear airway obstructions in
chronically infected adult CF patients. MPM was sterilized by
UV-irradiation and stored at 80°C. The addition of 10% MPM
to M63 medium did not significantly influence bacterial growth
rate (data not shown). Material collected from two different CF
patients (samples 1 and 2) was used to assess the effect of MPM
on global gene expression in wild-type P. aeruginosa. A single
sample (sample 1) was used for transcriptional profiling of the
rhlR, lasR double mutant. Duplicate experiments were per-
formed for each condition. For each experiment bacteria were
cultured to mid-exponential growth phase (OD600  0.5) and
total RNA was extracted at identical culture densities (con-
firmed by plating serial dilutions), converted to cDNA targets,
and hybridized to GeneChip P. aeruginosa Genome Arrays
(Affymetrix, Santa Clara, CA) as described (10).
Microarray Analysis. Hybridization data for all microarray exper-
iments was analyzed by using GENESPRING 4.2.1 software (Silicon
Genetics, Redwood City, CA) as described (10). See Table 1,
which is published as supporting information on the PNAS web
site, for a complete summary of microarray results. To identify
a common set of MPM-responsive genes, MPM samples from
two different patients were analyzed by microarray as described
above. Those genes that showed a statistically significant (P 
0.1) change in expression and a 5-fold change in magnitude
when grown in the presence of 10% MPM relative to M63
medium alone were regarded as significant. In total, 181 genes
met this condition, with 81 genes responding to sample 1 and 160
genes showing a response to sample 2. Sixty-one of the 181 genes
responded to both MPM samples. Of the remaining 120 genes
100 showed a similar trend; however, the response to one of the
two samples did not pass the statistical criteria described above
(Table 1). The remaining 20 genes represent a limited set of
patient-specific responses (Table 1).
Electron Microscopy. P. aeruginosa cultures were grown overnight
as described above in M63 alone or supplemented with 10%
MPM. A drop of culture was placed on a carbon-coated grid for
10 sec, excess liquid was drained, and the grid was rinsed in a
drop of saline and adherent cells stained with 1% aqueous uranyl
acetate for 30 sec. Samples were examined with a Hitachi H-7000
transmission electron microscope.
Reverse Transcription Polymerase Chain Reactions. Wild-type P.
aeruginosa was grown overnight in M63 and subcultured in either
M63 alone or supplemented with 10% MPM. Total RNA was
isolated at 0, 2, and 4 h after subculture. Reverse transcription
was performed by using 200 ng of each RNA sample, random
hexamer primer mix, and Superscript II reverse transcriptase
according to the manufacturers recommendations (Invitrogen).
After RNaseH digestion, 2 l of each cDNA sample were
amplified by PCR with primers specific for either fliC or the
constitutively expressed control gene clpX.
-Galactosidase Assays. A chromosomal fliC transcriptional re-
porter was engineered by cloning a 521-bp DNA fragment
carrying the fliC promoter and 107 base pairs of coding sequence
upstream of the lacZ gene encoding -galactosidase as described
(10). The resulting construct was moved onto the chromosome
of wild-type strain PAK and the isogenic mutants fliA, fliC, fliD,
and flgM (11–13). Before assays strains were grown overnight in
the presence and absence of 10% MPM, diluted into the same
medium, and grown for 3 h. -galactosidase activity was mea-
sured in triplicate and normalized based on colony-forming
units.
Results and Discussion
Using P. aeruginosa whole-genome DNA microarrays, we iden-
tified 61 genes that exhibited a statistically significant change of
5-fold after growth in M63 medium containing 10% MPM
from two different CF patients relative to M63 medium alone
(Fig. 1). This group includes 14 repressed and 47 activated genes.
Eight of the repressed genes encoded proteins involved in or
predicted to be involved in flagellar-mediated chemotactic mo-
tility, including six putative methyl-accepting chemotactic sensor
proteins, f lagellin, and a protein with homology to the flagellar
motor protein MotY.
Evidence indicates that flagella play a critical role in initial
colonization and acute infection and that they are important in
facilitating the formation of resilient bacterial communities or
biofilms (17–19). Despite the apparent importance of flagella in
the early stages of infection it has been shown that flagellin, the
structural subunit of the flagellar fiber, is recognized by the host
toll-like receptor 5 and leads to the mobilization of various
innate defense mechanisms via the NF-B signaling pathway (20,
21). In addition, it is known that flagellin-specific antibodies are
produced during CF lung infections and that flagellin can serve
as an efficient ligand for opsonic and nonopsonic phagocytosis
(22–25).
Given the dual role of P. aeruginosa f lagella as an important
virulence factor and a highly potent activator of host innate and
acquired immunity, we carried out a series of studies to corrob-
orate the findings of the DNA microarrays. Electron microscopic
examination demonstrated that flagella were absent from the
surface of 10% MPM grown P. aeruginosa, whereas these
structures were readily visible on the same bacteria grown in
medium lacking CF airway liquid (Fig. 2 A and B). Immunoblot
analysis of whole-cell protein extracts using flagellin specific
polyclonal antiserum showed that P. aeruginosa did not synthe-
size flagellin in the presence of MPM (Fig. 2C). In addition, the
kinetics of fliC repression was examined by reverse transcription
PCR (Fig. 2D). An 80% reduction in the amount of flagellin-
specific mRNA was detected after a 2-h exposure to 10% MPM.
After a 4-h exposure to 10% MPM, flagellin mRNA was almost
completely absent.
The flagellum of P. aeruginosa, like that of other bacteria, is
assembled in a hierarchical fashion in a process driven by the
sequential expression of flagellar genes in the order of their
assembly (11, 26). To determine whether the MPM response
correlated with a specific defect in the flagellar biosynthesis
pathway, we examined transcriptomes previously derived for a
set of flagellar regulatory mutants (11). The effect of MPM on
flagellar gene expression was most similar to that seen in a
mutant lacking the alternative sigma factor FliA (11, 27) (Fig.
3A). However, repression of fliA transcription does not account
for the results seen here, as fliA mRNA levels were unchanged
in MPM-containing medium relative to M63 alone (Table 1). In
light of this finding, we examined the effect of a mutation in flgM,
which encodes a FliA-specific anti-sigma factor (13), on fliC































transcription in the presence and absence of 10% MPM (Fig.
3B). The mutation in flgM resulted in an 17-fold increase in the
expression of a fliC::lacZ transcriptional reporter compared to
wild-type in M63 medium. However, in the absence of FlgM,
transcription from the fliC promoter was still repressed by
medium containing CF respiratory liquid (Fig. 3B). To examine
the possibility that flagellar binding of a mucus component
directly initiated a cessation of fliC expression we assayed the
effect of MPM exposure on transcription of the fliC::lacZ
reporter in mutants lacking flagellin or the mucin-specific
adhesin FliD (12) (Fig. 3B). In both cases, expression from the
fliC promoter was repressed by 10% MPM. These findings
suggest that the repressive signal likely acts through a previously
uncharacterized transcriptional mechanism that alters FliA func-
tion. Moreover, we have demonstrated that mutants that did not
assemble flagellar filaments or bind mucin are still subject to the
same repressive signal.
To access whether the host signal responsible for the shut-off
of f lagellin is restricted to MPM from CF patients, we examined
the transcriptional response of fliC to respiratory fluid collected
from individuals with non-CF bronchiectasis. Although the
Fig. 1. Cluster analysis (14) of P. aeruginosa genes showing altered expres-
sion after growth in the presence of MPM collected from the airways of
chronically infected CF patients. Indicated in the first and second columns are
genes showing a 5-fold change in expression in M63 medium containing
10% MPM collected from two different CF patients relative to M63 alone
(samples 1 and 2, respectively). Genes represented in green are repressed in
response to signal(s) present in the MPM samples. Genes in red are activated.
The role of the Rhl and Las QS systems in controlling the expression of these
MPM-responsive genes was determined by comparing gene expression in a
rhlR, lasR double mutant relative to wild type, both in the presence of 10%
MPM (sample 1). In the third column, genes represented in green require the
QS system for activation in MPM, genes in red require QS for repression in
MPM and genes in black are QS-independent (2-fold change). Black lines
indicate genes previously shown to be regulated by the QS system (15, 16).
Black dots denote genes specifically regulated by the Rhl QS system as inferred
from Schuster and coworker (15).
Fig. 2. Exposure to CF derived muco-purulent respiratory material results in
transcriptional repression of fliC, encoding flagellin. Electron microscopic
observation indicates that polar flagellar filaments, composed of flagellin
(arrows) are present (A) on the surface of P. aeruginosa grown in M63 medium
and absent (B) from the surface of bacteria grown in the same medium
containing 10% MPM. (C) Immunoblot analysis of whole-cell protein samples
with flagellin-specific antiserum confirms that P. aeruginosa grown in the
presence of 10% MPM produce significantly reduced amounts of flagellin
(arrow) compared to equivalent samples derived from bacteria grown in
medium lacking MPM. No flagellin is detectable in protein samples from
bacteria lacking the flagellin gene fliC. (D) Reverse transcription polymerase
chain reactions with fliC-specific oligonucleotide primers and total mRNA
extracted from wild-type P. aeruginosa at 0, 2, and 4 h after subculture in M63
medium with or without 10% MPM. Samples were equalized based on RT-PCR
products for the constitutively expressed clpX gene.























pathogenesis of this disease is poorly understood, it is charac-
terized by the chronic production of muco-purulent sputum,
neutrophil-dominated airway inflammation, and hypersuscepti-
bility to chronic and recurrent bacterial infections including P.
aeruginosa (28, 29). Using P. aeruginosa carrying the fliC::lacZ
transcriptional reporter, we demonstrated that M63 medium
containing non-CF bronchiectasis respiratory fluid was also
capable of repressing the transcription of fliC (data not shown).
The repression of flagellin in response to signals in chronically
infected host airway liquid may allow P. aeruginosa to avoid
clearance by phagocytosis. In fact, a number of studies have
shown that P. aeruginosa lacking flagella are resistant to phago-
cytosis by macrophages and polymorphonuclear leukocytes (25,
30). This observation is particularly relevant as the chronic phase
of CF lung infections is characterized by considerable neutrophil
dominated inflammation. Interestingly, most environmental P.
aeruginosa strains and those isolated early in CF infections are
highly motile, whereas those isolated from older chronically
infected CF patients show a high frequency of mutations leading
to the loss of flagellar formation (30). As such, it appears that
sustained genetic repression of flagellin expression in chronic
infections may be replaced by mutations that result in a perma-
nent adaptation.
Among the genes significantly activated in the presence of CF
MPM was rhlI encoding the N-butyryl-L-HSL (C4-HSL) auto-
inducer synthesis protein and a number of genes indicative of a
QS response (Fig. 1). The detection of a quorum response under
the low culture density conditions used in this study indicated the
presence of biologically significant levels of HSLs in the airway
fluids of chronically infected CF patients. This result was con-
sistent with previous studies which have shown that sputum
samples from CF patients colonized with P. aeruginosa contain
detectable levels of C4-HSL and N-3-oxododecanoyl-L-HSL
(3OC12-HSL) the autoinducers for the Rhl and Las QS systems,
respectively (9). Activation of the P. aeruginosa QS regulatory
network during chronic infections correlates with the formation
of polysaccharide encapsulated biofilm-like structures within
airway mucus plugs (7, 9, 31). These bacterial communities
appear to be highly resistant to innate and adaptive host defense
mechanisms (32, 33). In addition, the P. aeruginosa QS system
has been shown to control the expression of 6–10% of P.
aeruginosa genes, a number of which encode known extracellular
virulence factors (15, 16).
Given the significant role that QS plays in gene regulation, we
engineered a strain of P. aeruginosa lacking both of the quorum
responsive transcriptional regulators RhlR and LasR and ana-
lyzed gene expression in this strain after growth in 10% MPM-
containing medium. A substantial fraction of the MPM-
regulated genes were under the control of RhlR andor LasR
(Fig. 1). However, the expression of the MPM-repressed flagel-
lar genes including fliC and the chemotactic sensors did not
depend on RhlR or LasR, indicating that repression was inde-
pendent of QS (Fig. 1). This result was confirmed by assaying the
activity of the fliC::lacZ transcriptional fusion in the rhlR, lasR
double mutant grown in the presence and absence of 10% MPM
(data not shown).
Examination of the list of MPM-responsive genes that were
specifically dependent on the RhlR and LasR regulators
Fig. 4. Environment-specific QS gene response. Cluster analysis (14) of genes
that show CF respiratory liquid-specific patterns of QS-dependent expression
not previously identified under laboratory growth conditions. Indicated in the
first column are genes showing a 5-fold change in expression in wild-type P.
aeruginosa relative to a rhlR, lasR double mutant, both grown in M63 medium
containing 10% MPM. Green and red depict QS-dependent genes that are
repressed or activated, respectively, in 10% MPM. The second through fifth
columns represent the expression pattern of these genes at the indicated
culture densities (OD600) in laboratory medium supplemented with synthetic
autoinducers (rhlI, lasI mutant with added autoinducers versus no autoin-
ducer). Genes in green and red are repressed and activated, respectively, by
the addition of exogenous autoinducers. Genes in black are QS-independent
(2-fold change). Data for growth phase-dependent gene expression in the
presence of P. aeruginosa QS autoinducers has been published (15).
Fig. 3. The mechanism of fliC repression in response to MPM likely acts
through the alternative sigma factor FliA. (A) Presented is a comparison of the
transcriptional response of flagellar biogenesis genes in mutants lacking
known flagellar regulators relative to wild type and the expression change in
wild type grown in 10% MPM relative to medium lacking MPM. The transcrip-
tional response is given as the average fold change for each of the 14 flagellar
biogenesis gene operons (11). Expression data for the flagellar regulatory
mutants was derived from previously published transcriptomes (11). Black
bars, rpoN mutant vs. wild type; red bars, fleQ mutant vs. wild type; blue bars,
fleR mutant vs. wild type; green bars, fliA mutant vs. wild type; yellow bars,
wild type grown in M63 containing 10% MPM vs. M63 alone. (B) Response of
a fliC::lacZ transcriptional reporter in wild type and flagellar mutants in the
absence and presence of 10% MPM.































revealed that many had been previously identified during
recent exhaustive attempts to catalog QS responsive genes
under various laboratory conditions (15, 16) (Fig. 1). Many of
the most highly MPM-activated genes are specifically regu-
lated by the Rhl-dependent QS system implicated in biofilm
formation (9, 15, 31) (Fig. 1). In addition, our approach
showed that a number of genes, not identified as part of the QS
regulon under laboratory conditions, were significantly acti-
vated or repressed in the context of M63 medium containing
CF respiratory liquid (15) (Fig. 4). Of note is a putative operon
of five genes encoding a complete ABC transport system
(PA2327–PA2331), which was previously identified as acti-
vated by QS (15). Here we found that in the presence of CF
respiratory liquid, this cluster of genes is repressed by the QS
system (Fig. 4). These results highlight the fact that QS
signaling in the CF lung environment extends beyond the
network observed in laboratory media.
In summary, we have identified two major bacterial adaptive
responses that occur during growth in the presence of MPM
collected from the airways of chronically infected CF patients.
These responses included the repression of a subset of genes
involved in flagellar biogenesis and function and activation of a
set of HSL- or quorum-responsive genes. The findings presented
here indicate that during the course of CF respiratory infections
P. aeruginosa utilizes different strategies to evade host defenses
by systematically activating transcriptional programs in response
to the changing lung environment. As such, any antimicrobial
strategies aimed at preventing early infection in CF have to be
different from those used to treat chronically infected older
patients.
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